Sermorelin and GHRP-2: How the Peptide Stack Works and What to Know

Sermorelin and GHRP-2 are two different peptides that both raise growth hormone, but they act on separate receptors, which is why they are often discussed as a stack. Sermorelin signals the pituitary through the GHRH receptor, while GHRP-2 triggers a growth hormone pulse through the ghrelin receptor. Used together, they can produce a larger GH release than either one alone, but there is no FDA approval for this combination and no large human trial has tested it.

What Sermorelin Is

Sermorelin is a synthetic copy of the first 29 amino acids of growth hormone-releasing hormone, the signal the brain uses to tell the pituitary to release GH. It was FDA-approved as a diagnostic drug under the brand name Geref for evaluating pituitary function, and that product is no longer marketed in the United States.

Compounded sermorelin is sold by some clinics, but it is not FDA-approved for anti-aging, weight loss, or general wellness. Its half-life is short, roughly 10 to 20 minutes, which is part of the appeal: it mimics the body's natural, pulsatile GH rhythm instead of keeping growth hormone elevated all day.

What GHRP-2 Is

GHRP-2, also called pralmorelin, belongs to a different family known as growth hormone secretagogues. It binds the ghrelin receptor, or GHS-R1a, in the pituitary and hypothalamus and triggers GH release through a pathway sermorelin does not touch.

Unlike sermorelin, GHRP-2 nudges other hormones as well. Published research shows it can raise appetite, cortisol, prolactin, and aldosterone, which is one reason its side effect profile is considered broader. GHRP-2 is sold as a research chemical, is not FDA-approved for human use, and is banned by the World Anti-Doping Agency.

Why Sermorelin and GHRP-2 Are Stacked Together

When a GHRH analog and a ghrelin receptor agonist are given together, the resulting GH release is greater than the sum of the two given separately. Scientists describe this as a synergistic effect, and it is the main rationale behind the sermorelin and GHRP-2 combination.

The stack is also meant to feel more natural than injecting growth hormone directly. Sermorelin keeps the pituitary in the loop, so GH release stays subject to some of the body's own feedback signals. Many researchers also look into can you take cjc-1295 and sermorelin together when they want a longer-acting GHRH option instead of, or alongside, sermorelin.

Sermorelin vs GHRP-2 at a Glance

Feature	Sermorelin	GHRP-2
Class	GHRH analog	Ghrelin receptor agonist
Receptor	Pituitary GHRH receptor	GHS-R1a
Half-life	About 10 to 20 minutes	Roughly 20 to 30 minutes
Appetite	Little effect	Strongly increases hunger
Cortisol and prolactin	Minimal change at typical doses	Can raise both
FDA status	Approved only as a diagnostic; brand discontinued	Not approved for human use
Sports status	Banned by WADA	Banned by WADA

Typical Dosing and Timing Discussed in the Community

There is no validated dosing protocol for the sermorelin and GHRP-2 stack. What circulates online comes from small studies of each peptide alone, older bodybuilding forums, and clinic handouts, not from controlled trials of the pair.

Protocol element	Commonly reported approach	Notes
Sermorelin dose	100 to 300 mcg per injection	Studied alone as a diagnostic and in small GH deficiency trials
GHRP-2 dose	100 to 300 mcg per injection	Higher doses increase hunger and cortisol effects
Frequency	2 to 3 times daily	Each dose is meant to create a separate pulse
Timing	Before bed or post-workout, on an empty stomach	Food, especially carbohydrates, blunts the GH response
Cycle length	8 to 12 weeks, sometimes longer	No long-term safety data exist for the stack

Dosing before sleep is popular because the largest natural GH pulse occurs during early deep sleep. Anyone researching sermorelin and sleep will find claims about deeper rest and faster recovery, but those reports are anecdotal rather than proven.

Side Effects, Risks, and Legal Status

Both peptides can cause injection site irritation, flushing, headache, and fluid retention. GHRP-2 more often triggers intense hunger and a head-pressure sensation shortly after injection.

Because GHRP-2 raises cortisol and prolactin, repeated use may push those hormones outside their normal range. Elevated cortisol over time can affect blood sugar, mood, and immune function. Anyone researching sermorelin and diabetes should know that GH-raising peptides can work against insulin sensitivity, so people with diabetes or prediabetes need medical supervision before considering either peptide.

• Growth hormone and IGF-1 can promote tissue growth, so a personal or family history of cancer is usually treated as a reason to avoid GH-releasing peptides.
• GHRP-2 is sold for research use only, and buying it from a website does not make it a legal or safe human medicine.
• Pituitary disease, thyroid disorders, pregnancy, and use in children are typically excluded from peptide protocols.

Weighing sermorelin pros and cons is more useful than comparing before and after sermorelin photos, because online images are unverifiable and often involve several treatments given at once.

Questions to Ask Before Considering the Stack

1. Is there a diagnosed condition such as adult GH deficiency, or is the goal purely cosmetic or performance related?
2. Has a clinician checked baseline IGF-1, cortisol, prolactin, thyroid function, and fasting blood sugar?
3. Are you taking other peptides or glucose-lowering medications that could interact?
4. Is the product coming from a licensed compounding pharmacy with testing, or from an unverified research chemical supplier?

If a clinic offers sermorelin and GHRP-2 together, ask what monitoring is included. A responsible provider tracks bloodwork and stops the protocol when labs move in the wrong direction.

Sermorelin and GHRP-2 are not FDA-approved as a combined treatment for any condition. The stack is experimental, human data are sparse, and any use should be discussed with a licensed healthcare professional who can monitor labs and side effects.

COMMON QUESTIONS

Frequently Asked Questions

Can you stack sermorelin and GHRP-2 together?

They are often discussed as a stack because they act on different receptors, and combining a GHRH analog with a ghrelin receptor agonist produces a larger GH pulse than either alone. However, no human clinical trial has tested sermorelin and GHRP-2 together, and neither the combination nor GHRP-2 itself is FDA-approved for human use.

What does GHRP-2 do that sermorelin does not?

GHRP-2 binds the ghrelin receptor and also raises appetite, cortisol, and prolactin, while sermorelin mainly stimulates GH release through the GHRH receptor with minimal effect on those hormones. GHRP-2 tends to produce a sharper hunger response and a broader hormonal footprint, which is why it is viewed as the riskier half of the pair.

Is sermorelin and GHRP-2 legal in the United States?

Sermorelin is a prescription drug that was FDA-approved only as a diagnostic agent, and that brand is no longer marketed. GHRP-2 is not FDA-approved for human use at all and is typically sold as a research chemical, which means it is not a legal or tested medicine for people in the United States.